# Is the Vial You Received What the Label Says?

By Ruth Calder, Enforcement Editor (https://glpwatchdog.org/authors/ruth-calder) | Published: 2026-08-19 | Updated: 2026-11-06

Canonical page: https://glpwatchdog.org/research/verify-the-glp1-you-received

> FDA has found labels naming compounding pharmacies that do not exist, and labels naming real pharmacies that did not make the product. What to check when the box arrives, and what the 990 adverse event reports mean.

## Key points

- FDA found labels naming compounding pharmacies that DO NOT EXIST.
- Worse: real licensed pharmacy names printed on products they never made, so looking one up proves nothing.
- Arrived warm or under-iced? FDA's advice is not to use it. Chilling it later fixes nothing.
- 990 adverse event reports is a FLOOR, not a rate, because these pharmacies are not required to report at all.

Most advice about buying medication online stops at the moment you pay. This picks up after that, because the FDA’s published concerns are overwhelmingly about what turns up in the box. They include labels that name compounding pharmacies which **do not exist**, and labels naming real pharmacies that had nothing to do with the product inside.[1] If your check was “the label names a pharmacy”, that check does not work.

## The label is not evidence of who made it

The FDA has described fraudulent compounded semaglutide and tirzepatide sold in the United States carrying false information on the label. It describes two patterns: pharmacies named on the label that the agency could not find because they are not real, and the names of genuine licensed pharmacies printed on products those pharmacies did not compound.[1]

The second is the more unsettling of the two, because it defeats the obvious verification. You look up the pharmacy, it exists, it holds a real state license, everything checks out, and none of that says anything about the vial in your hand. The agency has one adverse event report tied to a product labeled as compounded tirzepatide from a pharmacy that did not compound it, with redness, swelling, pain and a lump at the injection site.[1]

> FDA has found the names of genuine licensed pharmacies printed on products those pharmacies did not compound.

The check that does work is to go the other way: contact the pharmacy or the telehealth company directly and ask them to confirm this order, this lot. FDA’s own guidance points patients to the compounder or the platform they bought from for exactly this kind of question.[1] If a seller cannot connect a lot number to a named pharmacy, treat that as a warning. [Collective](https://glpwatchdog.org/reviews/collective), which sells compounded semaglutide and tirzepatide, describes its suppliers on its site only as regulated US pharmacy partners, so that question goes to the company itself.

That call is simpler when you already know whom to ask, so note which pharmacy your seller says it uses before the box arrives. Some name a single one. [EdgeRx](https://glpwatchdog.org/reviews/edgerx) names Strive Pharmacy, [CeliaRx](https://glpwatchdog.org/reviews/celia-rx) says it works only with [Partell Pharmacy](https://glpwatchdog.org/pharmacies/partell-specialty-pharmacy), and [OurView Health](https://glpwatchdog.org/reviews/ourview-health) names Boudreaux’s New Drug Store in Louisiana. [Docberry](https://glpwatchdog.org/reviews/docberry) names Olympia Pharmaceuticals, [Mixx Health & Wellness](https://glpwatchdog.org/reviews/mixx-health-and-wellness) names Promise Pharmacy, and [JumpstartMD](https://glpwatchdog.org/reviews/jumpstartmd) names PerfectRx for its compounded options.

[Nex Gen Health Rx](https://glpwatchdog.org/reviews/nexgen-health-rx) gives one footer address for both itself and Manifest Pharmacy in Greer, South Carolina, and [CLYR Health](https://glpwatchdog.org/reviews/clyr-health) names The Pharmacy Hub in Miami as the pharmacy that fills its vials. [NuviaRx](https://glpwatchdog.org/reviews/nuviarx) lists two pharmacies that may fill an order, Manifest Pharmacy and RX Compounding Store, so with a seller like that the label tells you which of the two to call, and the call tells you whether it was them. [Direct Meds](https://glpwatchdog.org/reviews/direct-meds) also names two, CraftedRx in Missouri and ChemistryRx in Pennsylvania, and says which states each one fills.

## Counterfeits of the brand product too

This is not only a compounding story. The FDA has said it is aware of counterfeit Ozempic marketed in the United States. Counterfeits claim to be authentic while potentially containing the wrong ingredients, too little or too much active ingredient, none at all, or something harmful.[1]

Buying the brand does not by itself remove this risk; buying the brand *from a state-licensed pharmacy* is what does. Our [verification guide](https://glpwatchdog.org/research/how-to-verify-an-online-glp1-pharmacy) covers how to establish that a pharmacy is what it claims to be.

## If it arrives warm, the answer is no

Injectable GLP-1 drugs need refrigeration, and their package inserts say so. The FDA has received complaints about compounded GLP-1s arriving warm, or with too little ice to have kept them cold in transit, and its recommendation is not to use a product that arrives that way.[1] Sellers rarely tell you in advance how they prevent it: in our register, 192 advertise free or included shipping, and [29 say anything about keeping it cold](https://glpwatchdog.org/research/who-tells-you-how-your-glp1-ships).

- **Open the box the day it lands**, not the evening you plan to inject. If it sat on a doorstep all afternoon, the warming has already happened, and opening it later only delays finding out.
- **Photograph the ice pack and the box before you unpack.** If you need to ask for a replacement, that photograph is your evidence.
- **Melted or missing ice is what counts**, however the vial looks, because degraded product looks completely normal.
- **Do not put it in the fridge and use it anyway.** Chilling something afterward does not undo the excursion.

> Branded pens have published, drug-specific tolerances, and they differ sharply, as our table of [how long each GLP-1 can be out of the fridge](https://glpwatchdog.org/research/glp1-storage-out-of-the-fridge) shows. A Zepbound single-dose pen may be kept unrefrigerated for up to 21 days in total, while an unused Ozempic pen belongs in the fridge until its first use (the 56 days on its label start after that). Our [storage and travel cheat sheet](https://glpwatchdog.org/research/cheat-sheets/glp1-pen-storage-and-travel-cheat-sheet) has every label’s numbers. A compounded vial has no such published window; it carries whatever beyond-use date the pharmacy assigned, which you have to ask for.

## The dosing errors are their own category

The FDA has received multiple reports of adverse events, some requiring hospitalization, that may relate to dosing errors with compounded injectable semaglutide. These came from patients measuring and self-administering the wrong amount, and in some cases from clinicians miscalculating the dose.[1]

Vials make this error easy in a way pens do not. A pen meters the dose; a vial and syringe ask you to produce it, from a concentration the pharmacy chose. Our [unit converter](https://glpwatchdog.org/tools/glp1-unit-converter) does that arithmetic, but the safest approach is to have the prescriber write the dose in units for the exact concentration you were sent.

Separately, the agency has had reports involving doses beyond what the approved labeling describes: more product per dose, doses taken more often, or titration climbing faster than the label schedule.[1] If a plan you have been given moves faster than the label, ask about it before the next injection.

## What the adverse event counts do and do not tell you

As of May 31, 2026, the FDA had received 990 reports of adverse events associated with compounded semaglutide and more than 730 associated with compounded tirzepatide.[1] Those numbers are quoted often, and almost always wrongly.

They are not rates. Nobody knows how many people took compounded GLP-1s over the same period, so there is no denominator and no percentage can be built from them. And they are floors rather than totals, because federal law does not require state-licensed pharmacies that are not outsourcing facilities to report adverse events to the FDA at all. The agency says that events from compounded versions are likely underreported.[1]

> The FDA also notes that many of the adverse events reported for compounded products look consistent with those reported for the approved versions.[1] That is reassuring, though it falls short of a safety finding, because the reporting channel it comes through is voluntary and incomplete at both ends.

If something happens to you, the reporting route is MedWatch, and it takes a few minutes.[1] Given that pharmacies in this category are not obliged to report, a patient report may be the only way a given problem is ever counted.

## Frequently asked questions

### How do I know my compounded GLP-1 came from a real pharmacy?

Not from the label. FDA has found labels naming compounding pharmacies that do not exist, and labels naming real licensed pharmacies that did not make the product. Contact the pharmacy or the telehealth platform directly and ask them to confirm your order and lot number.

### My medication arrived warm. Can I still use it?

FDA's recommendation is not to use an injectable GLP-1 that arrives warm or with insufficient refrigeration. Photograph the box and ice pack before unpacking, and ask for a replacement. Refrigerating it after the fact does not reverse the excursion, and degraded product looks completely normal.

### Are there counterfeit versions of the brand drugs?

Yes. FDA has said it is aware of counterfeit Ozempic marketed in the United States. Counterfeits may contain the wrong ingredients, the wrong amount, none at all, or something harmful. Buying from a state-licensed pharmacy is the protection, not buying the brand as such.

### Do the 990 adverse event reports mean compounded semaglutide is dangerous?

They do not tell you that either way. There is no denominator, so no rate can be calculated, and they are a floor rather than a total, because state-licensed pharmacies that are not outsourcing facilities are not required to report adverse events at all, and FDA says events from compounded versions are likely underreported.

### Why are dosing errors more common with compounded product?

Because a pen meters the dose and a vial does not. Drawing from a vial means producing the dose yourself from a concentration the pharmacy chose, and FDA has reports of adverse events, some requiring hospitalization, from patients and clinicians getting that arithmetic wrong.

## References

1. U.S. Food and Drug Administration. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss — drug alert, content current as of October 1, 2026. FDA. 2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss

---

Cite as: GLP Watchdog, Ruth Calder, "Is the Vial You Received What the Label Says?", published 2026-08-19, updated 2026-11-06. https://glpwatchdog.org/research/verify-the-glp1-you-received

Canonical HTML page: https://glpwatchdog.org/research/verify-the-glp1-you-received

Medical disclaimer: Nothing here is medical advice. We report on this subject; we do not treat anyone. Whether to begin a medication, supplement, or treatment, whether to adjust it, and whether to stop are questions for a clinician licensed to answer them, who knows your history.
